Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesStratified phase II trial of cetuximab in patients with recurrent high-grade glioma
Annals of Oncology, 06/05/09
Neyns B et al. - Cetuximab was well tolerated but had limited activity in this patient population with progressive HGG. A minority of patients may derive a more durable benefit but were not prospectively identified by EGFR gene copy number.
Related Articles
Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT
Journal of Neuro-Oncology, 10/30/09
Relevance Score: 68%
A Phase II Study of Cisplatin and Temozolomide in Heavily Pre-treated Patients with Temozolomide-refractory High-grade Malignant Glioma
Anticancer Research, 11/13/09
Relevance Score: 66%
Treatment of recurrent high-grade gliomas
Current Opinion in Neurology, 11/12/09
Relevance Score: 66%
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas
Neuro-Oncology, 10/05/09
Relevance Score: 66%
Data Presented On Oncophage Cancer Vaccine In Recurrent Glioma At SNO 2009
Antigenics, 10/30/09
Relevance Score: 65%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma
European Journal of Cancer, 12/04/09
PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells
BMC Cancer, 12/04/09
Pathologic complete response of a solitary melanoma brain metastasis after local ablative radiation therapy: case report
Medical Oncology, 12/03/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma
European Journal of Cancer, 12/04/09
Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: Results of a pharmacokinetic study
European Journal of Cancer, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor